To help keep up with the dynamic landscape in nuclear medicine fueled by theranostics, AuntMinnie offers the Radiopharmaceutical Therapy (RPT) Tracker. Reach us at [email protected] with new entries or updates.
Last Updated: October 7, 2026 ↓
Latest News: October 6, 2026 ▾
AuntMinnie Coverage
Nuclidium images first patient in phase II trial of Cu-61 PSMA tracer
October 6, 2026 · Nuclidium · Cu-61 NU101
GE HealthCare to acquire Sofie Biosciences for $945M
October 5, 2026 · GE HealthCare · SOFIE Biosciences
FDA clears new PET agent for brain cancer imaging
September 14, 2026 · Telix · Pixclara
Curium gets FDA approval for Lu-177 injection for GEP-NETs
September 14, 2026 · Curium · Bexlutry
Telix completes enrollment in BiPASS study
September 2, 2026 · Telix · Illuccix/Gozellix (Ga-68 PSMA-PET)
Norroy secures FDA breakthrough therapy, fast-track status for PET imaging agent
August 19, 2026 · Norroy Biosciences · Ga-68 NYM096
Curium to acquire Lantheus in $8 billion deal
August 4, 2026 · Curium · Lantheus
Novartis secures expanded approval for Pluvicto
August 4, 2026 · Novartis · Pluvicto
Lutetium-177 PSMA-617 shows promise in earlier-stage prostate cancer
July 23, 2026 · Novartis · Pluvicto
AdvanCell raises $315M for targeted alpha therapy
July 15, 2026 · AdvanCell · ADVC001
| Company | Drug (Isotope) / Imaging Agent | Indication(s) / Target | Stage |
|---|
No programs match your filters.
